Schedule 13G ownership disclosure

Akebia Therapeutics Inc

Security class unavailable · CUSIP: 00972D105

Event date: 2017-11-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,312,403
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-066647
Form type
SC 13G/A
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Nov 07, 2017
Reporting period
Nov 03, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub